Amanda Compadre, MD
“RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer”
Hybrid
Amanda Compadre, MD
Gynecologic Oncology Fellow (PGY-5)
Department of Obstetrics and Gynecology
Washington University in St. Louis
Host/Lab: Mullen
View more information on Dr. Compadre’s research »